Walgreens Says Insulin Pen Settlement Suit Has No 'Heat'
By Jeff Montgomery ( November 20, 2023, 7:51 PM EST) -- An attorney for pharmacy giant Walgreens' parent company told a Delaware vice chancellor on Monday that a stockholder derivative complaint seeking more than $200 million from directors who allegedly ignored intentional overfilling of insulin pen prescriptions amounted to "little light and no heat."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.